Back
Oncternal Therapeutics Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Sell
35
ONCT
Oncternal Therapeutics
Last Price:
1.29
Seasonality Move:
21.38%
Sell
39
NBY
NovaBay Pharmaceuticals
Last Price:
0.70
Seasonality Move:
-7.72%
Sell
35
Oncternal Therapeutics (ONCT)
is a Sell
Is Oncternal Therapeutics a Buy, Sell or Hold?
- The current Oncternal Therapeutics [ONCT] share price is $1.27. The Score for ONCT is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- ONCT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $0.69. The Score for NBY is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- NBY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ONCT Stock Price Chart
What is Oncternal Therapeutics's stock price today?
-
The Oncternal Therapeutics share price today is $1.27
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ONCT is experiencing selling pressure, which indicates risk of future bearish movement.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.69
The current trend is relatively stagnant and NBY is experiencing slight buying pressure.
ONCT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.12 | Sell |
Relative Strength Index (14 RSI): | 39.87 | Sell |
Chaikin Money Flow: | -99296 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.2 - 1.66) | Sell |
Bollinger Bands (100): | (1.6 - 6.64) | Sell |
NBY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.02 | Buy |
Relative Strength Index (14 RSI): | 53.8 | Buy |
Chaikin Money Flow: | 74506 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.6 - 0.72) | Buy |
Bollinger Bands (100): | (0.3 - 1.7) | Sell |
ONCT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.49 | Sell |
20-day SMA: | 1.48 | Sell |
50-day SMA: | 1.92 | Sell |
200-day SMA: | 6.5 | Sell |
8-day EMA: | 1.47 | Sell |
20-day EMA: | 1.52 | Sell |
50-day EMA: | 2.22 | Sell |
200-day EMA: | 5.5 | Sell |
NBY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.73 | Sell |
20-day SMA: | 0.65 | Buy |
50-day SMA: | 0.61 | Buy |
200-day SMA: | 2.57 | Sell |
8-day EMA: | 0.7 | Sell |
20-day EMA: | 0.68 | Buy |
50-day EMA: | 0.74 | Sell |
200-day EMA: | 6.08 | Sell |
Oncternal Therapeutics Earnings Growth & ONCT Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.51 per share, and an increase next year of $1.64 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $78.20 per share, and an increase next year of $1.81 per share.
Oncternal Therapeutics Technical Analysis
Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NovaBay Pharmaceuticals Technical Analysis
Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |